Skip to main content

Table 2 Resistance rates of ESBL and Non-ESBL isolates to TET, CIP, CN and SXT

From: Predictors of blaCTX-M-15 in varieties of Escherichia coli genotypes from humans in community settings in Mwanza, Tanzania

Antibiotic

NON-ESBL (n = 279)

ESBL (n = 55)

Total (n = 334)

P value

Tetracycline

119 (42.7 %)

44 (80 %)

163 (48.8 %)

p < 0.001

Ciprofloxacin

6 (2.1 %)

37 (67.2 %)

43 (12.9 %)

p < 0.001

Gentamicin

14 (5.2 %)

34 (61.8 %)

48 (14.4 %)

p < 0.001

Co-trimoxazole

184 (66.6 %)

52 (94.5 %)

216 (64.7 %)

p < 0.001

  1. SXT Trimethoprim/sulphamethoxazole, TET tetracycline, CN gentamicin and CIP ciprofloxacin